TrialScientific reports2017

Clinical and Immunological Effects of rhIL-2 Therapy in Eastern Chinese Patients with Multidrug-resistant Tuberculosis.

Qi Tan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.